www.hhs.gov U.S. Department of Health and Human Services

Online Learning

A printed, recorded, or computer-presented activity that endures over a specified time and does not have a specific time or location designated for participation; rather, the participant determines whether and when to complete the activity.

26 matches found
Title Type
FDA’s Role in Postmarketing Drug Safety Surveillance Enduring Material 
How FDA and ISMP Utilize Medication Error Reports to Improve Drug Safety Enduring Material 
Overview of Expanded Access (EA) Program and EA eRequest Site Enduring Material 
Biosimilar and Interchangeable Biosimilars: Review of Scientific Concepts, Case Studies, and Resources Enduring Material 
Fraudulent Products – Hidden Ingredients and Unproven Claims in Products Marketed as Dietary Supplements Enduring Material 
Enhanced Drug Distribution Security: 2023 and Beyond Enduring Material 
Safety Labeling Changes for Leukotriene Receptor Antagonists and Decisions Behind a Boxed Warning Enduring Material 
Project Facilitate: Oncology Expanded Access Program Update Enduring Material 
FDA’s Office of Orphan Products Development (OOPD) – An Overview and Update Enduring Material 
The Ins and Outs of Prescription Drug Labeling Enduring Material 
Orange Book: Frequently Asked Questions and Answers Enduring Material 
Counseling Patients on Generic Drugs Enduring Material 
Labeling Made Simple: The How, What, and Where of Drug Interactions in Prescribing Information Enduring Material 
An Overview of Naloxone and FDA’s Efforts to Expand Access Enduring Material 
Overview of Risk Evaluation and Mitigation Strategies (REMS) for Health Care Providers Enduring Material 
Pregnancy and Lactation Medication Information for the Healthcare Provider Enduring Material 
FDA Drug Information Resources and Applicability to Health Care Professionals Enduring Material 
Reporting and Public Viewing of Individual Case Safety Reports (ICSRs) Enduring Material 
Drug Shortages: Root Causes and Potential Solutions Enduring Material 
Engaging Providers to Address Knowledge Gaps on Medication Use in Pregnancy and Lactation -- Enduring Material Enduring Material 
Development and U.S. Regulation of Preventive Vaccines Enduring Material 
Understanding Generic Narrow Therapeutic Index Drugs Enduring Material 
The Safety Evaluation and Surveillance of Generic Drugs Enduring Material 
Frequently Asked Questions about Labeling for Prescription Medicines Enduring Material 
Assessment of Stromal Tumor-Infiltrating Lymphocytes Enduring Material 
PCOS Revisited: Diagnosis, Management, and Future Needs Enduring Material 
Back To Top
ACCME Joint Accreditation
  • This warning banner provides privacy and security notices consistent with applicable federal laws, directives, and other federal guidance for accessing this Government system, which includes (1) this computer network, (2) all computers connected to this network, and (3) all devices and storage media attached to this network or to a computer on this network.
  • This system is provided for Government-authorized use only.
  • Unauthorized or improper use of this system is prohibited and may result in disciplinary action and/or civil and criminal penalties.
  • Personal use of social media and networking sites on this system is limited as to not interfere with official work duties and is subject to monitoring.
  • By using this system, you understand and consent to the following:
    • The Government may monitor, record, and audit your system usage, including usage of personal devices and email systems for official duties or to conduct HHS business. Therefore, you have no reasonable expectation of privacy regarding any communication or data transiting or stored on this system. At any time, and for any lawful Government purpose, the government may monitor, intercept, and search and seize any communication or data transiting or stored on this system.
    • Any communication or data transiting or stored on this system may be disclosed or used for any lawful Government purpose.